The National Kidney Foundation announced plans to update its KDOQI Clinical Practice Guideline for Diabetes and Chronic Kidney Disease, first published in 2007.



“A revised diabetes and chronic kidney disease guideline will include
recent studies focusing on the management of hyperglycemia such as the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial; we are aiming to complete the update process within a year, to ensure that practitioners and patients benefit from new knowledge as soon as possible.  A draft is expected to be available for public review by January 2011,” said KDOQI Chair, Michael Rocco, MD of Wake Forest School of Medicine in North Carolina.


“Our understanding of the diagnosis and management of diabetic kidney disease (DKD) is evolving rapidly and we want to ensure that the KDOQI guidelines reflect current knowledge,"  said guideline co-chair Dr. . Katherine Tuttle, Medical and Scientific director of research at Providence Medical Research Center in Spokane, Washington. "Moreover, findings from several recent trials suggest that certain drug treatment strategies widely believed to be beneficial for diabetic patients may in fact offer little benefit and may, in some settings, even be harmful,” 


The KDOQI Evidence Review Team is currently assessing the literature before the work group begins writing.  This process will be followed by a public review of the draft before its final publication next year.